Why the study?
Does female sex increase the risk of primary efficacy failure and cardiovascular rehospitalization in patients undergoing catheter ablation for paroxysmal atrial fibrillation?
Population
750 patients with drug-refractory symptomatic paroxysmal atrial fibrillation, mean age 60.0±9.5 years, 61%…
Comparison
Female sex vs Male sex
Design
Cohort, 1:1
Follow-up
average follow-up of 1.5 years (maximum 33 months)
Authors
Loading...
May warrant closer monitoring in women; leaves open whether sex-specific ablation strategies improve paroxysmal AF outcomes.
Does female sex increase the risk of primary efficacy failure and cardiovascular rehospitalization in patients undergoing catheter ablation for paroxysmal atrial fibrillation?
Female sex is associated with an approximately 40% higher risk of arrhythmia recurrence and cardiovascular rehospitalization following catheter ablation for paroxysmal atrial fibrillation.
Kück et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: